Michael A. Rogawski

Active 1976–2025

108
Papers
21,247
Citations
89
h-index
107
i10-index

Citations

Citations per year for Michael A. Rogawski1912: 1 citations1976: 1 citations1977: 7 citations1978: 8 citations1979: 3 citations1980: 9 citations1981: 16 citations1982: 13 citations1983: 18 citations1984: 11 citations1985: 14 citations1986: 17 citations1987: 18 citations1988: 31 citations1989: 21 citations1990: 20 citations1991: 42 citations1992: 44 citations1993: 48 citations1994: 68 citations1995: 63 citations1996: 64 citations1997: 106 citations1998: 79 citations1999: 106 citations2000: 108 citations2001: 91 citations2002: 114 citations2003: 120 citations2004: 157 citations2005: 139 citations2006: 206 citations2007: 185 citations2008: 169 citations2009: 137 citations2010: 172 citations2011: 153 citations2012: 145 citations2013: 176 citations2014: 151 citations2015: 127 citations2016: 175 citations2017: 135 citations2018: 105 citations2019: 418 citations2020: 539 citations2021: 523 citations2022: 310 citations2023: 313 citations2024: 367 citations2025: 153 citations2026: 3 citations1913–1975: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,207 citing papers, 31.6% of this breakdownGermany: 450 citing papers, 6.4% of this breakdownUnited Kingdom: 446 citing papers, 6.4% of this breakdownItaly: 418 citing papers, 6% of this breakdownChina: 374 citing papers, 5.4% of this breakdownFrance: 280 citing papers, 4% of this breakdownCanada: 270 citing papers, 3.9% of this breakdownJapan: 216 citing papers, 3.1% of this breakdownAustralia: 201 citing papers, 2.9% of this breakdownSpain: 143 citing papers, 2% of this breakdownNetherlands: 134 citing papers, 1.9% of this breakdownIndia: 124 citing papers, 1.8% of this breakdown
0%31.6%Other 24.6%

Fields

  • Neuroscience37.8%
  • Medicine35.2%
  • Biochemistry, Genetics and Molecular Biology20.4%
  • Psychology1.1%
  • Computer Science1.1%
  • Agricultural and Biological Sciences1%
  • Other3.4%

Topics

  • Neuroscience and Neuropharmacology Research15.4%
  • Epilepsy research and treatment7.9%
  • Ion channel regulation and function4.6%
  • Pharmacological Effects and Toxicity Studies3.7%
  • Amino Acid Enzymes and Metabolism2.2%
  • Diet and metabolism studies2.2%
  • Other64%

Coauthors

All papers

Open in search
  1. Mechanisms of action of currently used antiseizure drugs

    Authors: , - Neuropharmacology 2020 cited by 486

  2. Glia and epilepsy: excitability and inflammation

    Authors: , , , , - Trends in Neurosciences 2013 cited by 860

  3. d -Serine is an endogenous ligand for the glycine site of the N -methyl- d -aspartate receptor

    Authors: , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2000 cited by 1,129

  4. Blood-brain barrier dysfunction in aging induces hyperactivation of TGFβ signaling and chronic yet reversible neural dysfunction

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2019 cited by 257

  5. Mechanisms of Action of Antiseizure Drugs and the Ketogenic Diet

    Authors: , , - Cold Spring Harbor Perspectives in Medicine 2016 cited by 328

  6. Commonalities in epileptogenic processes from different acute brain insults: Do they translate?

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Epilepsia 2017 cited by 279

  7. The neurobiology of antiepileptic drugs

    Authors: , - Nature reviews. Neuroscience 2004 cited by 1,231

  8. Molecular Targets for Antiepileptic Drug Development

    Authors: , - Neurotherapeutics 2007 cited by 465

  9. The Neuropharmacological Basis for the Use of Memantine in the Treatment of Alzheimer's Disease

    Authors: , - CNS Drug Reviews 2003 cited by 435

  10. Efficacy and Safety of XEN1101, a Novel Potassium Channel Opener, in Adults With Focal Epilepsy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sami Aboumatar, Stephanie Callow, Shahram Izadyar, Robert Wechsler, Jerzy P. Szaflarski, Nathan B. Fountain, Imran Ali, George Li, Theresa Rodgers-Neame, Elizabeth Waterhouse, Selim R. Benbadis, Steve Chung, Maria Sam, Joanne Rogin, Eric Segal, Claude Steriade, Amir Arain, Richard Pellegrino, Kenneth D. Laxer, Mushtaque Chachar, Conrad C Nievera, Max Benzaquen, David Gloss, Ahmed Sadek, Lixin Zhang, Wei Ma, Aashit Shah, James Valeriano, Heidi Henninger, Jeffrey Tsai, Brian D. Moseley, Ruben Kuzniecky, Jerry J. Shih, Gregory Cascino, Alberto Pinzon-Ardila, Elizabeth E. Gerard, Samiya Rashid, Utku Uysal, Samuel Destefano, William O. Tatum, Suparna Krishnaiengar, Raymond Faught, Eric B. Geller, Rolando Ania, Baljeet Sethi, Barbara Phillips, Micaela Chatman, Eric Segal, A. Lerman, Naoir Zaher, Ricardo Ayala, Michael Gelfand, David Lesch, David G. Vossler, Paul D. Lyons, Ruben Kuzniecky, David Steiner, Martín del Campo, Jean‐François Clément, Seyed M. Mirsattari, Mary Connolly, Craig Heath, M. I. Richardson, Khalid Hamandi, Elizabeth Galizia, Kathleen M. White, Anthony G Marson, Rhys H. Thomas, Bernhard J. Steinhoff, Christian Brandt and 36 more - JAMA Neurology 2023 cited by 55

  11. Adjunctive perampanel for refractory partial-onset seizures

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Noe Barroso, Albino Contreras Milian, Sarug Reyes Morales, Ildefonso Rodríguez‐Leyva, Sanjay Jain, Angus A. Wilfong, Arun Kalra, Ben Renfroe, David Moore, J. Robert Flamini, Jack A. Klapper, Jerzy P. Szaflarski, Jean Teasley, Jonathan J. Halford, José Alexandre Ferreira, Hewitt C. Goodpasture, Michael R. Sperling, Pavel Klein, Ricardo Ayala, Richard Brower, Robert Leroy, Ronald L. Davis, Roy D. Elterman, Thomas Enlow, Verónica Sosa, Vinay Puri, J. Philip Miller, Bassel F. Shneker, Ramon Edmundo D. Bautista, Steve Chung, David Lesch, David F. Steiner, Randall Webb, Robert Armstrong, Victor Biton, Gregory L. Krauss, Wendy G. Mitchell, R. Edward Hogan, Robert C. Knowlton, James W. Wheless, R. Aung-Din, Imran Ali, Lawrence W. Brown, Michael Gruenthal, Pongkiat Kankirawatana, Michael Charlet, Joan A. Conry, Meriem Bensalem Owen, Mark S. Yerby, Craig Herrman, Albert Fessler, Pradeep N. Modur, Fernando Pellon de Miranda, David King‐Stephens - Neurology 2012 cited by 477

  12. Neuroprotective and disease-modifying effects of the ketogenic diet

    Authors: , , - Behavioural Pharmacology 2006 cited by 456

  13. The Neuropharmacology of the Ketogenic Diet

    Authors: , , , - Pediatric Neurology 2007 cited by 321

  14. Current understanding of the mechanism of action of the antiepileptic drug lacosamide

    Authors: , , , , - Epilepsy Research 2014 cited by 206

  15. Revisiting AMPA Receptors as an Antiepileptic Drug Target

    Authors: - Epiliepsy currents/Epilepsy currents 2011 cited by 315

  16. Jasper's Basic Mechanisms of the Epilepsies [Internet]

    Authors: , , , , - 2012 cited by 205

  17. Stress-Induced Deoxycorticosterone-Derived Neurosteroids Modulate GABAAReceptor Function and Seizure Susceptibility

    Authors: , - Journal of Neuroscience 2002 cited by 275

  18. Preclinical pharmacology of perampanel, a selective non-competitive AMPA receptor antagonist

    Authors: , - Acta Neurologica Scandinavica 2013 cited by 238

  19. AMPA receptors as a molecular target in epilepsy therapy

    Authors: - Acta Neurologica Scandinavica 2013 cited by 225

  20. Evidence for the involvement of the kainate receptor subunit GluR6 (GRIK2) in mediating behavioral displays related to behavioral symptoms of mania

    Authors: , , , , , , , , , , - Molecular Psychiatry 2008 cited by 177

  21. Common Pathophysiologic Mechanisms in Migraine and Epilepsy

    Authors: - Archives of Neurology 2008 cited by 156

  22. Safety, tolerability, and pharmacokinetics of allopregnanolone as a regenerative therapeutic for Alzheimer's disease: A single and multiple ascending dose phase 1b/2a clinical trial

    Authors: , , , , , , , , , , , , , , , - Alzheimer s & Dementia Translational Research & Clinical Interventions 2020 cited by 32

  23. Clinical spectrum of succinic semialdehyde dehydrogenase deficiency

    Authors: , , , , , , , , , , - Neurology 2003 cited by 210

  24. Anticonvulsant Activity of Progesterone and Neurosteroids in Progesterone Receptor Knockout Mice

    Authors: , , , - Journal of Pharmacology and Experimental Therapeutics 2004 cited by 181